XPAR
CGM
Market cap163mUSD
Sep 03, Last price
10.40EUR
Name
Cegedim
Chart & Performance
P/E
—
P/S
0.22
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
5.38%
Revenues
654m
+6.25%
Net income
-15m
L+98.57%
CFO
102m
+4.01%
Dividend
Jun 29, 20220.5 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cegedim SA is a global technology and services firm specializing in managing digital data flows within the healthcare ecosystem and for B2B clients. The company also publishes business software tailored for healthcare and insurance professionals across the world. Its operations are divided into two main segments: Health Insurance, HR & e-Services, and Healthcare Professionals. The Health Insurance, HR & e-Services division provides a wide array of products and services to various insurance entities, including insurance companies, mutuals, personal protection insurers, and brokers, while also facilitating their interactions with healthcare providers. This segment additionally offers hosting services, outsourced HR and payroll management, and electronic data interchange solutions. Concurrently, the Healthcare Professionals division supplies essential management software, specialized databases, and various solutions to medical doctors, allied health practitioners, pharmacists, and healthcare facilities. Established in 1969, Cegedim SA's corporate headquarters are located in Boulogne-Billancourt, France. It operates as a subsidiary of FCB SA.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||